SCM
MDT icon

Smead Capital Management’s Medtronic MDT Stock Holding History

Smead Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-403,022
Closed -$29.1M – 33
2014
Q4 		$29.1M Buy
403,022
+46,890
+13% +$3.26M 2.68% 20
2014
Q3 		$22.1M Sell
356,132
-492
-0.1% -$31.3K 2.38% 21
2014
Q2 		$22.7M Buy
356,624
+16,383
+5% +$995K 2.48% 21
2014
Q1 		$20.9M Buy
340,241
+42,126
+14% +$2.45M 2.52% 20
2013
Q4 		$17.1M Buy
298,115
+23,694
+9% +$1.34M 2.36% 21
2013
Q3 		$14.6M Buy
274,421
+43,225
+19% +$2.33M 2.37% 22
2013
Q2 		$11.9M Buy
+231,196
New +$11.4M 2.41% 22

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Smead Capital Management's MDT Position: Q1 2015 in Review

Smead Capital Management sold out of Medtronic (MDT) in Q1 2015, closing a stake of 403,022 shares — an estimated $29.1M sold.

Smead Capital Management first reported a position in MDT in Q2 2013 and held it in 7 quarters. The position peaked at $29.1M in Q4 2014. 1,246 funds tracked by Wall St. Rank hold MDT as of Q1 2015.

  • Smead Capital Management reported no remaining Medtronic position as of Q1 2015 after selling out during the quarter.
  • Smead Capital Management sold 403,022 Medtronic shares in Q1 2015, an estimated $29.1M.
  • Smead Capital Management first reported a position in Medtronic in Q2 2013 and held it in 7 quarters.
  • Smead Capital Management's Medtronic position peaked at $29.1M in Q4 2014.
  • 1,246 funds tracked by Wall St. Rank held Medtronic as of Q1 2015.

Based on Smead Capital Management's 13F filing for Q1 2015, filed 8 May 2015.